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Abstract: The preparation of new active pharmaceutical ingredient (API) multicomponent crystal
forms, especially co-crystals and salts, is being considered as a reliable strategy to improve API
solubility and bioavailability. In this study, three novel imidazole-based salts of the poorly
water-soluble salicylic acid (SA) are reported exhibiting a remarkable improvement in solubility
and dissolution rate properties. All structures were solved by powder X-ray diraction. Multiple
complementary techniques were used to solve co-crystal/salt ambiguities: density functional theory
calculations, Raman and 1H/13C solid-state NMR spectroscopies. In all molecular salts, the crystal
packing interactions are based on a common charged assisted +N-H(SA)  O (co-former) hydrogen bond
interaction. The presence of an extra methyl group in dierent positions of the co-former, induced
dierent supramolecular arrangements, yielding salts with dierent physicochemical properties.
All salts present much higher solubility and dissolution rate than pure SA. The most promising results
were obtained for the salts with imidazole and 1-methylimidazole co-formers.
Keywords: salicylic acid; imidazole; salts; powder X-ray diraction; ssNMR; DFT
1. Introduction
The discovery of new active pharmaceutical ingredients (APIs) having poor water-solubility and
bioavailability has become prevalent during the drug development process [1–3]. The responsibility
for maintaining a consistent bioavailability throughout product life has led to regulatory requirements
for polymorphism-screening experiments, which is described in the ICH Q6A (Specification: Test
Procedures and Acceptance Criteria for New Substances and New Drug Products: Chemical
Substances) [4]. Furthermore, the pharmaceutical industry has also been interested in using crystal
engineering principles to prepare new multicomponent API solid forms based on the intermolecular
interactions established between the APIs and a general recognized as safe co-former [5–8]. This strategy
allows the improvement of the APIs’ ecacy; enhancing their physicochemical properties without
changing their pharmacological behavior [6].
The accurate study of the intermolecular interactions opens the possibility to understand API
physicochemical behavior and that of their multicomponent crystal forms [7,8]. For that, structural
information is needed and is conventionally obtained from X-ray diraction. The particular use of
powder X-ray diraction (PXRD) for structure determination of inorganic/organic and pharmaceutical
systems has been exploited in several studies [1,9–15]. This approach revealed to be a powerful tool,
especially for systems in which the crystallization into single crystal is limited or dicult.
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Depending on the position of the labile hydrogen atom, engaged in the hydrogen bonds, API solid
forms can be defined as co-crystals or salts [16]. The distinction between the two is an important
demand by the food and drug administration guidelines. To this end, Raman, solid-state NMR (ssNMR)
and density functional theory (DFT) calculations have been used as complementary techniques to
help locating the position of light atoms, such as hydrogens, and study packing interactions such
as hydrogen bonds (HBs) [17–19]. Here, we use this powerful combination, not only for structural
validation, but also for accurately study the HB packing interactions and relate them with some
physicochemical properties.
Salicylic acid (SA, Figure 1a) is a phenolic molecule also known as ortho-hydroxybenzoic acid or
2-hydroxybenzoic acid. This compound has antiseptic, preservative, analgesic and anti-inflammatory
properties, covering a broad spectrum of applications, including skin-care products [20,21]. SA as
free acid has a very low solubility in water (2.17 mg/mL) and it is normally administrated as sodium
salt [21]. However, this form is not well regarded, as it exhibits some toxicity and has the tendency to
cause gastrointestinal irritation [22]. To surpass the SA solubility issues, Kawashima and co-workers
developed a strategy consisting on spray drying SA, dispersed in acacia solutions, improving its
solubility by 50% [23]. Furthermore, the dissolution rate was also improved, being about 60 times
faster than pure SA. Those results were related not only to the acacia concentration, but also to the
amount of amorphous material in the spray-dried product. Ananikov and co-workers also reported
some increases in SA solubility through the preparation of ionic liquids based on alkyl imidazole
derivatives [24].
In the last decade, the propensity of SA to produce multicomponent crystal forms was extensively
studied and the results showed a tendency to obtain ring synthons, when co-crystals are obtained, and
dierent HB patterns upon salts formation [25–41]. Only for one of the reported studies, the SA solubility
was slightly improved when co-crystallized with ethenzamide [42]. Until today, no other publications
reporting the synthesis of SA co-crystals/salts to improve physicochemical/biological properties were
published. Taking this into account and considering the low SA aqueous solubility, as well as the
limitations of the available sodium form, we present herein the synthesis and characterization of three
new SA molecular salts with improved solubility and dissolution rate properties. For this purpose,
SA was combined with imidazole (IMI) and two derivatives, 1- and 2-methylimidazole (1-MEIM and
2-MEIM) (Figure 1). Imidazoles are ubiquitous in nature (e.g., amino acids) and play a critical role in
many structures and functions within the human body [43]. Furthermore, their derivatives (e.g., 1-alkyl
imidazoles) and salts are known to be biocompatible, exhibiting antimicrobial and antifungal activities,
which make them good co-former candidates for the preparation of multicomponent pharmaceutical
forms [44].
Molecules 2019, 24, x FOR PEER REVIEW 2 of 16 
2 
 
a powerful tool, especially for systems in which the crystallization into single crystal is limited or 
difficult. 
e e i   t  position of the labile hydrogen atom, engaged in the hydroge  bonds, API 
s lid forms can be d fined as co-cry tals or salts [16]. The distinction betw en the t o i   i rta t 
e   the f od an  drug administration guidelines. To this end, Raman, solid-state  
(ssNMR) and density functional theory (DFT) calculatio s have been used as complementary 
techniques to l  locating the position of light atoms, such as hy rogens, and study packing 
interacti ns such as hydrogen bonds (HBs) [17–19]. Here, e use this powerful c mbination, not only 
for structural validati n, but also for accurat ly study the HB p king interactions and rela e them 
with some physicochemical properties.  
Salic lic i  ,  ) is a phenolic molecule also known as ortho-hydroxybenzoic acid 
or 2-hydroxybenzoic acid. This compound has antiseptic, preservative, analges c nd nti-
inflammatory properties, covering a broad s ectrum of applications, including skin-care products 
[20,21]. SA as free acid has a very low solubility in water (2.17 mg/mL) and it is normally 
administrated as sodium salt [21]. Howev r, this form is not well regarded, as it ex ibits some toxicity 
and has the tende cy to cause gastrointestinal irritation [22]. To rpass the SA solubility issu s, 
Kawashima and co-workers devel ped a strategy consist ng on spray dry ng SA, dispersed in acac a 
solutions, improving its solubility by 50% [23]. F rthermore, the dissoluti n rate was als  improved, 
being about 60 times fa ter than pure SA. Th se results were related ot only to the acacia 
concentration, but also to the mount of amorphous material in the spray-dried product. Ananikov 
and co-worker  also rep rted some increases in SA solubility through the preparation of ionic liquids 
based on alkyl imidazole derivatives [24]. 
I  t  last decade, the ropensity of SA to produce ulticomponent crystal forms was 
extensively s udi d and the resul s showed a tendency to ob ain ring synthons, when c -crystals re 
obtained, and different HB patterns upon salts formation [25–41]. Only for one of the reported 
studies, the SA solubility was slightly improved when co-crystallized with ethenzamide [42]. Until 
today, no other publications eporting the synth sis of SA co-crystals/s ts to improve 
hys cochemical/biological properties were published. Taking this into account and con id ring t e 
low SA aqueous solubility, as well as the limitatio s of the available sodium form, w  prese t herein 
th  synthesis and characterization of three new SA molecular salts with improved solubility and 
dissolution rate properties. For this purpose, SA w s combine  with im dazole (IMI) and two 
derivatives, 1- and 2- ethylimidazole (1-MEIM a d 2-MEIM) (Figure 1). Imidazoles re ubiquitous 
in nature (e.g., amino a ids) and play a critical role in many st uctures an  func ons within the 
hum n body [43]. Furtherm re, heir derivatives (e.g., 1-alkyl imidazoles) nd salts are known to be 
biocomp tible, xhibiting anti icrobial and antifungal activi es, which make them good co-former 
candidates for the preparation of multicomponent pharmaceutical forms [44].  
a)  b) c) d) 
Figure 1. Molecular representation of protonated a) SA; b) IMI; c) 1-MEIM and d) 2-MEIM with their 
pKa values. 
2. Results and Discussion 
In this work, we intended to obtain new multicomponent crystal forms of SA, so co-former 
selection was based in its biological safety, capacity to participate in HB interactions and ΔpKa rule 
(if ΔpKa ≥ 3 salts are obtained, for ΔpKa ≤ 1 co-crystals) [45]. Three new salts were prepared 
mechanochemically through the milling of SA with IMI, 1-MEIM and 2-MEIM, under room 
Figure 1. Molecular representation of protonated (a) SA; (b) IMI; (c) 1- EIM and (d) 2-MEIM with
their pKa values.
2. Results and Discussion
In this work, we intended to obtain new multicomponent crystal forms of SA, so co-former
selection was based in its biological safety, capacity to participate in HB interactions and DpKa
rule (if DpKa  3 salts are obtained, for DpKa  1 co-crystals) [45]. Three new salts were prepared
mechanochemically through the milling of SA with IMI, 1-MEIM and 2-MEIM, under room temperature
conditions and in absence of solvents. All reactions were completed, as no trace of starting materials
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were observed in the final products. Since the crystallization of these salts into single crystals was
dicult and considering that solution synthesis normally requires large quantity of solvent and more
time to be conducted, mechanochemistry is used as a reliable powerful procedure for the preparation
of pharmaceutical salts and co-crystals with high purities and yields.
The packing features of the three new SA salts, together with their dissolution rate, solubility and
thermal stability properties, are presented and thoroughly discussed. Furthermore, a combination
of PXRD with Raman, ssNMR and DFT calculations were performed for all compounds in order to
confirm and validate the salt formation.
2.1. Structural Analysis
The powdered samples were indexed as orthorhombic unit cells, using both TOPAS [46,47]
and DICVOL [48] in DASH [49] program without ambiguity (see Table 1). Using Hofmann’s
volume increments [50], the expected molecular volume was 247.3 Å3 and 271.3 Å3 for SA:IMI and
SA:1-MEIM/SA:2-MEIM, respectively. Those volumes corresponds to 8 molecules in the unit cell (Z = 8)
for a unit cell volume varying between 2019.92 Å3 and 2239.1 Å3 (Table 1). As starting configuration
models, SA, IMI, 1-MEIM and 2-MEIM were taken from the CSD (see experimental section) and used in
the simulated annealing process (real space method) to solve all structures. These structures were then
refined by the Rietveld method (Figure 2). For the best final models, an optimization of hydrogen and
non-hydrogen atoms was performed by DFT calculations. Results show that the models obtained by
simulated annealing are correct and suggest more stable structures in which the labile proton, initially
located in the SA carboxylic acid group, migrates to the nitrogen atom of all co-former molecules (IMI,
1-MEIM and 2-MEIM), forming 1:1 molecular salts. Raman data (Figures S1–S4) confirm the salts
formation, as the SA C-O (COOH) vibrational band at 1635.9 cm 1, shifts towards values between
1629.5 cm 1 and 1627.2 cm 1, with a remarkable decrease in the intensity, supporting the presence of
carboxylate groups. Furthermore, these results are also in agreement with the DpKa rule (3.97–4.88),
which supports the salt formation.
Table 1. Crystallographic details for salicylic acid (SA) salts.
SA:IMI SA:1-MEIM SA:2-MEIM
Chemical formula C10H10N2O3 C11H12N2O3 C11H12N2O3
Formula weight/gmol 1 206.2 220.23 220.23
Crystal system Orthorhombic Orthorhombic Orthorhombic
Space group Pbca Pbca Pbcn
a/Å 16.6736(3) 24.9283(3) 10.8972(6)
b/Å 11.08182(19) 8.00291(6) 9.2671(5)
c/Å 10.9319(2) 10.98695(11) 22.1726(11)
V/Å3 2019.92(6) 2191.89(4) 2239.10(2)
Z 8 8 8
Rp, R’p/% 1 1.097, 10.065 1.179, 7.251 1.569, 7.136
Rwp, R’wp/% 1 1.514, 6.427 1.584, 5.495 2.056, 6.371
Rexp, R’exp/% 1 1.126, 4.779 1.067, 3.701 1.105, 3.234
RBragg 0.70378 0.57544 0.81733
Gof 1.345 1.485 1.752
1 Dashed values corresponds to values after background subtraction.
Unambiguous assignment of 13C ssNMR resonances was achieved by plotting the theoretical
chemical shielding (iso) against the experimental CSs (iso(exp)) (Figure 3). As can be observed, there is
a good correlation between both iso and iso(exp) variables, indicating that the models solved by
PXRD are reliable. In the case of SA:1-MEIM, it was possible to assign the 1H resonances as the signal
resolution was good enough. For SA:IMI and SA:2-MEIM (Figures S5 and S9), such assignment was
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not possible due to the very poor resolution of 1H NMR spectra. All ssNMR spectra are presented in
Figures S5–S10.
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The HB network of SA:IMI is based on an intramolecular S(6) O-H(SA) : : : O (SA), dH : : : O = 1.76(8)
Å, intermolecular N-H(IMI)  O (SA), dH : : : O = 1.78(7) Å (mode I) and bifurcated +N-H(IMI)  O (SA),
dH : : : O = 1.82(7) and 2.35(7) Å (mode II) HB interactions, which enable the formation of a chain
composed by alternated SA:IMI molecules (Figure 4a). In the full packing structure, the presence of a
channel formed by two independent crossed-chains is evident and supported by D6h - interactions
between SA and IMI molecules, d : : :  = 3.8 and 4.1 Å (Figure 4b). Furthermore, additional weak
C-H(IMI)  (SA), dH : : :  = 2.6 Å (in T-shaped form, C2v) and C-H(IMI)  O(SA), dH : : : O = 2.4 Å and
2.6 Å intermolecular interactions act as a bridge in the interconnection between the chains (Figure 4c).
Contrarily to SA:IMI, the co-former used in the preparation of SA:1-MEIM has one of the HB
acceptors (nitrogen atom) blocked by a methyl group. The packing structure is now breaking from
crossed-chains to small independent layers (Figure 5b), composed by one SA and one 1-MEIM
molecules which are interacting through N-H(1-MEIM)  O (SA), dH : : : O = 1.72(7) Å HB, mode II
(Figure 5). The weak C-H(1-MEIM)  O(SA), dH : : : O = 2.3 and 2.6 Å interaction plays a similar rule
as described for the previous salt, helping the packing growing in all directions and allowing the
interconnection between the layers. The stability of this interconnection occurs due to the additional
C-H(1-MEIM)   (SA), dH : : :  = 2.7 Å HB. This interaction can be easily detected by 1H ssNMR, as the
iso(exp) of one of the methyl group hydrogen atoms is shifted towards higher field in comparison
with the other two (Figure 6 and Table S2). The direct eect of imidazole ring current gives electron
density to the hydrogen atom, directly pointed to the middle of the ring, resulting in a shielded eect.
The hydrogen atoms involved in the N-H(1-MEIM)  O (SA) and O-H(1-MEIM)  O (SA) HBs appear,
as expected, at lower field due to the deshielded eect of the oxygen atom that participates in the
HB interaction.Molecules 2019, 24, x FOR PEER REVIEW 6 of 16 
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and one SA carboxylate group (mode I), +N-H(2-MEIM)⋯O−(SA), dH…O = 1.72(7) Å and N-H(2-MEIM)⋯O−(SA), 
dH…O = 1.78(6) Å. Each 2-MEIM molecule has a different orientation (up and down) with respect to 
the plane formed by the SA molecule. The difference in the orientation is caused by the steric 
hindrance of the methyl group, forcing the molecules to deviate from each other. This orientation is 
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type of HB connectivity like in SA:IMI, but with a dierent pattern (Figure 7). There is an intramolecular
HB between the SA hydroxyl and carboxylate groups, which is never broken in all salts systems,
and two independent HB interactions are established between two 2-MEIM molecules and one SA
carboxylate group (mode I), +N-H(2-MEIM)  O (SA), dH : : : O = 1.72(7) Å and N-H(2-MEI )  O (S ,
d : : : O = 1.78(6) Å. Each 2-MEIM molecule has a dierent orientation (up and down) with respect
to the plane formed by the SA molecule. The dierence in the orientation is caused by the steric
hindrance of the methyl group, forcing the molecules to deviate from each other. This orientation is also
supported and stabilized by the weak C-H(2-MEIM)  (2-MEI ), dH : : :  = 2.6 interaction established
bet een the t o 2- EI olecules. In the overall packing structure, the orientation of the strong
S : : : 2-MEIM HB interactions induce the formation of intercalated zig-zag chains along b.
Molecules 2019, 24, 4144 7 of 16
Molecules 2019, 24, x FOR PEER REVIEW 7 of 16 
7 
 
 
Figure 6. 1H MAS NMR spectrum of SA:1-MEIM with signal attribution obtained from the correlation 
between δiso(exp) and σiso. See experimental section for acquisition details and supplementary material. 
SA:1-MEIM layer is also displayed, highlighting the weak C-H(IMI)⋯π(SA) interaction. 
In SA:2-MEIM, the co-former methyl group changes from the nitrogen position to the carbon 
located between the nitrogen atoms of imidazole ring. The packing structure now evidences a similar 
type of HB connectivity like in SA:IMI, but with a different pattern (Figure 7). There is an 
intramolecular HB between the SA hydroxyl and carboxylate groups, which is never broken in all 
salts systems, and two independent HB interactions are established between two 2-MEIM molecules 
and one SA carboxylate group (mode I), +N-H(2-MEIM)⋯O−(SA), dH…O = 1.72(7) Å  and N-H(2-MEIM)⋯O−(SA), 
dH…O = 1.78(6) Å . Each 2-MEIM molecule has a different orientation (up and down) with respect to 
the plane formed by the SA molecule. The difference in the orientation is caused by the steric 
hindrance of the methyl group, forcing the molecules to deviate from each other. This orientation is 
also supported and stabilized by the weak C-H(2-MEIM)⋯π(2-MEIM), dH…π = 2.6 Å  interaction established 
between the two 2-MEIM molecules. In the overall packing structure, the orientation of the strong 
SA…2-MEIM HB interactions induce the formation of intercalated zig-zag chains along b.  
 
Figure 7. Zig-zag packing arrangement of alternated SA/2-MEIM molecules, along b, evidencing the 
+N-H(2-MEIM)⋯O−(SA) and C-H(2-MEIM)⋯π(2-MEIM) HB interactions. 
Figure 7. ig-zag packing arrange ent of alternated S /2- EI olecules, along b, evidencing the
+ - (2-MEIM)  O (SA) and C-H(2-MEIM)  (2-MEIM) HB interactions.
2.2. Structure-Property Relationships
Dissolution rate, solubility and thermal stability studies were performed for all SA compounds
and a tentative attempt to correlate the structures with the properties was undertaken.
Figure 8 shows the plot with the dissolution rate studies performed for both SA and SA salts.
The duplicates for SA:IMI and SA:2-IMI show a very good correlation. A minor oset in the SA:IMI
measurements might be caused by some uncertainty in time of addition, as the second tablet of SA:IMI
was floating a short time before sliding down to the bottom of the beaker. Due to the high concentration
of the samples, the UV-VIS spectra of all salts show saturation at the end of the study. As the aim of
this experiment was to follow the dissolution rates of the materials compared to pure SA, only the first
data points of the step are of interest and the fact of saturation at the end was considered as negligible.
As expected, all studied salts dissolve much faster than pure SA (Figure 8). This result can be
somehow explained by the changes in the pH of the API micro-environment, during the dissolution
process, such that more API dissolves in the diusion layer that surrounds the particles, being faster
dissipated into the bulk medium [51].
Dissolution rate is a complex physicochemical property and can be intimately related with
several microscopic properties such as particle size, surface area, packing eciency and dierent salt
counter-ions [52]. In Figure 8 is visible that SA:IMI and SA:1-MEIM show very similar dissolution
behavior, while SA:2-MEIM seems to dissolve more slowly. A possible explanation can be the dierent
packing features. As can be observed in Figure 9, SA:IMI and SA:1-MEIM have similar molecular
arrangements (along b), regardless of the dierent HB patterns previously discussed. The cavities
observed along b (Figure 9, green highlight) can probably help in the water diusion into the lattice,
accelerating the dissolution process. In SA:2-MEIM, no cavities are observed (along all directions),
despite having the lower packing eciency (68.6%), which in turn should give a higher dissolution
rate in comparison to the other salts (Figure 9).
Preliminary solubility studies in water show a drastically improvement in SA solubility, with the
following order: SA:2-MEIM < SA:IMI < SA:1-MEIM (Figure 9). This order is inverse compared to the
co-formers solubility: 1-MEIM < IMI < 2-MEIM. SA:2-MEIM, which exhibits the lowest dissolution
rate also has the lowest solubility.
As SA belongs to class II of the biopharmaceutical classification system, increasing aqueous
dissolution rate and solubility is one of the key factors for improving its bioavailability. In general,
salts can stay in solution in a supersaturated state and might not precipitate immediately, even if the
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pH of the gastrointestinal tract favors the insoluble free acid formation. Supersaturation can leave,
in fact, a wider time window for the API absorption. Nevertheless, when salt precipitation occurs,
amorphous forms as well as fine particles are normally obtained, which have higher dissolution rate
and also higher bioavailability [51].
Regarding the thermal stability, from DTA data (Figures S11–S13), all salts show a similar
decomposition temperature (Tonset between 192 C and 205 C), a lower melting point than pure
SA (approximately 158.6 C) and absence of phase transitions or solvents. SA:IMI has a higher
melting point than SA:1-MEIM and SA:2-MEIM, presenting the most stable lattice. Furthermore, the
heat required to break the salts interactions, directly proportional to the DHfus, follows the order:
SA:1-MEIM < SA:2-MEIM < SA:IMI. In Figure 9 are presented the main synthons observed for each SA
salt. The charged assisted HB distances found in each system are very similar (Table 2) and the main
dierence is the type and number of connections, which can possibly influence the observed trend. For
SA:IMI there are two strong HB interactions in two modes (I and II) and for SA:2-MEIM also two strong
HB interactions, but in mode I. In addition, for SA:IMI, there are also several weak HB interactions
(CH  O, CH   and - ), which together with the strong ones, helps to stabilize the structure.
In SA:1-MEIM, only mode II is observed, but because the hydrogen atom is not in the center of
the bifurcated interaction, one of the distances is much higher than the other one, and hence only one
strong interaction is observed (1.72 Å), which can explain the lower heat energy required.Molecules 2019, 24, x FOR PEER REVIEW 9 of 16 
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3. Materials and Methods
3.1. Synthesis
All reagents were purchase from Sigma Aldrich and used without further purification. SA:IMI,
SA:1-MEIM and SA:2-MEIM were mechanochemically synthesized using a vibratory ball mill (Retsch
MM400 horizontal mill, Haan, Germany). SA and co-formers were weighted into a stainless-steel
vessel (milling jar 10 mL) in an equimolar ratio with a total mass of 1 g. Mixtures were ground using
two stainless-steel balls ( 10 mm, 4 g) at 30 Hz for 25 min, under room temperature conditions (25 C,
55% humidity) and in absence of solvents.
3.2. Powder X-Ray Diraction (PXRD)
Data collection was performed at room temperature on a D8 Discover diractometer (Bruker AXS,
Karlsruhe, Germany), using Cu radiation (Cu K 1,  = 1.5406 Å), a Johansson monochromator, and a
position-sensitive LYNXEYE detector. Sample was contained in a rotating glass capillary with 0.5 mm
diameter, mounted horizontally and spun at 60 min 1 for minimizing preferred orientation. Data were
collected in a 2 from 5 to 60 with a step size of 0.009 and 9 s per step.
Powder patterns were indexed using DICVOL [4,8] in DASH [49] and TOPAS [46,47]. Structure
solution was achieved by the real-space method, using simulated annealing routine implemented in
DASH [49]. The starting models of SA, IMI, 1-MEIM and 2-MEIM molecules were obtained from
the CIF files of CSD (Cambridge Structural Database) with the entries SALIAC [53], IMAZOL01 [54],
BARMIM [55] (only the 1-MEIM structure) and FULPIM [56], respectively. During simulated annealing
no restrictions in the degrees of freedom of each molecule was applied.
Rietveld refinement was carried out using TOPAS [46,47] for the full 2 range. A Pawley fit was
first performed and in the following refinement steps, the scale factor, background, atomic positions,
and isotropic displacement parameters were refined.
For all structures, two dierent isotropic displacement parameters were refined: one for the
non-hydrogen (non-H) atoms of each SA and IMI, 1-MEIM and 2-MEIM molecules, and another one for
the hydrogen atoms of both SA and IMI, 1-MEIM and 2-MEIM, Biso(H) = 1.2  Biso(non-H). Restraints
were applied for all bond lengths, angles, and planar rings/groups. Data collection and structure
refinement details are summarized in Table 1. All information about HB distances and angles for all
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compounds, obtained using PLATON [57], are presented in Table 2. CCDC 1958159-1958161 contain
the supplementary crystallographic data for this paper. These data can be obtained free of charge from
The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures.
Table 2. Hydrogen-bond distances and angles for the reported crystal salts.
Structure sym op D-H  A d(D-H)(Å)
d(H  A)
(Å)
d(D  A)
(Å)
DHA
(deg)
SA:IMI
x, y, z
x, 3/2   y,  1/2 + z
2   x, 1   y, 1   z
2   x, 1   y, 1   z
O-H(SA)  O  (SA)
N-H(IMI)  O  (SA)
+N-H(IMI)  O  (SA)
+N-H(IMI)  O  (SA)
0.91(7)
0.94(7)
0.94(7)
0.94(7)
1.76(8)
1.78(7)
2.35(7)
1.82(7)
2.525(9)
2.698 (12)
3.093(10)
2.733(11)
140(7)
163(6)
135(5)
161(6)
SA:1-MEIM
x, y, z
x, y, z
x, y, z
O-H(SA)  O  (SA)
N-H(IMI)  O  (SA)
+N-H (1-MEIM)  O  (SA)
0.93(8)
0.93(7)
0.93(7)
1.65(7)
2.53(7)
1.72(7)
2.523(10)
3.128(13)
2.649(14)
154(7)
122(6)
176(8)
SA:2-MEIM
x, y, z
1/2   x, 1/2 + y, z
1 + x, y, z
O-H(SA)  O  (SA)
N-H (IMI)  O  (SA)
+N-H (IMI)  O  (SA)
0.93(7)
0.94(6)
0.94(7)
1.74(8)
1.78(6)
1.72(7)
2.551(10)
2.725(12)
2.654(10)
144(7)
176(8)
172(7)
3.3. Density Functional Theory (DFT) Calculations
DFT calculations were performed with Quantum Espresso (QE) package using the Perdew-Burke-
Ernzerhof exchange-correlation function [58]. The molecular models were obtained by the periodic
expansion of the crystallographic unit cells for SA:IMI, SA:1-MEIM and SA:2-MEIM systems.
The computational procedure consisted in a first optimization of the atomic positions, followed
by calculation of the NMR parameters using the GIPAW approach [59]. The pseudopotentials of the
norm-conserving Troullier-Martins [60] type with GIPAW [59] reconstruction were taken from other
references [61,62]. The cuto energy for the plane waves was set as 30 Ryd, and Monkhorst-Pack
k-points grids of 1  2  2 (SA:IMI), 1  2  2 (SA:1-MEIM) and 2  2  1 (SA:2-MEIM) were employed.
QE default values for convergence criteria were used. The calculated 13C isotropic iso were plotted as
a function of the iso(exp). For SA:1-MEIM, a plot with the 1H iso and iso(exp) values were performed
as the experimental data had enough resolution for signal attribution. Reference values were obtained
from the equation plots traced for each salt system (Figure 2). Conversion of the calculated iso into
the corresponding iso(DFT) was performed according to
iso(DFT) = (iso   ref)/m (1)
where ref and m are the intercept and slope of the regression model, respectively, obtained from the
best fit.
3.4. Solid-State Nuclear Magnetic Resonance (ssNMR)
Magic angle spinning (MAS) solid-state NMR spectra (Figures S5–S10) were acquired on a Bruker
Avance 400 spectrometer operating at a B0 field of 9.4 T with Larmor frequencies of 400.1 MHz and
100.6 MHz for 1H and 13C, respectively. All 1H and 13C NMR experiments were recorded using a
double-resonance 4 mm Bruker MAS probe at a spinning rate of 10 KHz. The isotropic chemical shift
values are given with respect to TMS (0 ppm) using adamantane as secondary standard for 1H and
13C measurements.
1H-MAS studies were made with a /2 pulse lengths of 3.2 s, a recycle delay of 5 s and
16 accumulations.
The 1H-13C CPMAS NMR spectra were acquired using a contact time of 1 ms and a recycle delay
of 5 s. The accumulation number (ns) is given in the caption of the respective figure.
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3.5. Thermal Stability Studies
Thermal gravimetric analyses (TG) and dierential thermal analyses (DTA) were simultaneously
recorded by a thermobalance SETARAM TAG 24. Measurements were conducted in flowing nitrogen
(35  10 5 L/s) after repeated evacuation (3  10 2 mbar) on powdered samples placed in open
platinum crucibles (100 L) at a heat rating of 10 K/min up to a maximum temperature of 300 C.
Cooling to room temperature was carried out at  30 K/min followed by one repetition of this heating
and cooling procedure. For correction of buoyancy eect the data of the second run were subtracted
from the first run. The sample mass was recorded with an accuracy of  0.01 mg.
3.6. Solubility Studies
Preliminary solubility studies were carried out by dissolving 10 mg of each molecular salt in
water, gradually added until reaching complete dissolution and saturation. The amount of added
water allowed the determination of empirical solubility values and SA was used for comparison.
Table 3 shows the results obtained.
Table 3. Preliminary solubility results obtained for SA, SA:IMI, SA:1-MEIM and SA:2-MEIM.
Compound Solubility (mg/mL)
SA 2.38
SA:IMI 1304.3
SA:1-MEIM 2195.0
SA:2-MEIM 1162.2
3.7. Dissolution Rate Studies
Samples were compressed to tablets with a hydraulic press to ensure reproducible conditions.
These tablets were dropped in a round-bottom glass beaker filled with 60 mL of deionized water and
equipped with a motor driven PTFE centrifugal stirrer shaft running at 500 rpm (EURO-ST P CV,
IKA-Werke GmbH & Co. KG., Staufen, Germany). The solution was pumped to the UV-VIS flow cell
(Z-geometry, self-made construction, PEEK, 1 mm optical path) with a peristaltic pump (Ismatec Reglo
Analog, Cole-Parmer GmbH, Wertheim, Germany) at a pump speed setting of 75%, which equals a
flow rate of 7.4 mL/min. The measurements were done using a UV-VIS spectrometer (MultiSpec Pro,
tec 5 AG, Oberursel, Germany) acquiring a spectral range of 190–720 nm with a sampling rate of 500 ms
for SA salts and 10 s for pure SA. Absorbance data was collected as ASCII, combined using a python
script and evaluated by univariate monitoring of the maximum intensity at 296 nm. Data was plotted
for comparison using Origin (Origin 2018G, OriginLab Corporation, Northhampton, MA, USA).
A total of five SA salts samples, as well as two samples of pure SA were studied with the UV-VIS
setup. The measurements on SA:IMI and SA:2-MEIM were performed in duplicates. Due to some issues
with compressing the sample of SA:1-MEIM there was only a single tablet available of this material.
As an example, the acquired spectra of SA:2-MEIM (1st assay), Figure 10, clearly shows the build-up of
signals in the UV-range from 200–350 nm. For the univariate data approach, the well-separated signal
at 296 nm was chosen for intensity evaluation.
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4. Conclusions
Three novel imidazole-based salts of SA were mechanochemically prepared and their structural
characterization performed using PXRD combined with spectroscopic techniques. Analysis of 1H and
13C-CPMAS NMR data along with Raman spectra and DFT calculations was helpful in determining
the deprotonation state of SA carboxylic group, allowing unambiguous identification of salt forms.
The supramolecular arrangement of all molecular salts is based on strong +N-H(SA)  O-(co-former) HB
interactions and the full packing changes depending upon the presence and position of the co-former
methyl group. The packing structure of SA:IMI is based on independent crossed-chains and, when
the co-former has one of the HB donor position blocked by a methyl group, the packing changes
being mainly composed by small independent layers. Interestingly, in a perspective along c, both
packing structures present similar small cavities. In this case, the face to face methyl group position in
1-MEIM substitutes the normal strong HB interaction between SA and IMI, producing the same visual
eect. In the case of SA:2-MEIM, the methyl group located between the imidazole nitrogen atoms, now
unblock the nitrogen donor position, being in a similar situation observed for SA:IMI. However, due to
the steric hindrance induced by the methyl group, the two 2-MEIM co-formers, which are interacting
with the SA carboxylate group, deviate from each other, being positioned above and below the planar
ring of SA, thus helping in the formation of zig-zag chains.
Physicochemical studies show that all salts present much higher solubility and faster dissolution
rate than SA as free acid. Since the dissolution rate also depends on the structure packing, in our
results there is an apparent relation between the two properties for the case of SA:IMI and SA:1-MEIM.
Both structures present cavities along c, which we believe to help water to diuse into the lattice.
This somehow explains why they present similar dissolution rate profiles. In terms of thermal stability,
all salts present lower melting points than SA free acid. The strength of the HBs is similar for all salts
and the dierence lies in the number and type of interactions. SA:IMI has more interactions (strong
and weak, type I and II) than the other salts and hence is more stable, presenting both highest melting
point and heat. The results herein presented show that all SA salts are promising candidates to be used
as new solid forms for SA delivering.
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NMR spectra of SA:IMI, Figure S6: 13C CP-MAS NMR spectra of SA:IMI, Figure S7: 1H MAS NMR spectra of
SA:1-MEIM, Figure S8: 13C CP-MAS NMR spectra of SA:1-MEIM, Figure S9: 1H MAS NMR spectra of SA:2-MEIM,
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SA:1-MEIM and Figure S13: DTA curve of SA:2-MEIM.
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